Your browser doesn't support javascript.
loading
Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
Barbash, G I; Birnbaum, Y; Bogaerts, K; Hudson, M; Lesaffre, E; Fu, Y; Goodman, S; Houbracken, K; Munsters, K; Granger, C B; Pieper, K; Califf, R M; Topol, E J; Van De Werf, F.
Affiliation
  • Barbash GI; Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. gabi@tasmc.health.gov.il
Circulation ; 103(7): 954-60, 2001 Feb 20.
Article in En | MEDLINE | ID: mdl-11181469
Subject(s)
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Streptokinase / Thrombolytic Therapy / Tissue Plasminogen Activator / Coronary Disease / Myocardial Infarction Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2001 Type: Article
Search on Google
Print
XML
PubMed Links

Database: MEDLINE Main subject: Streptokinase / Thrombolytic Therapy / Tissue Plasminogen Activator / Coronary Disease / Myocardial Infarction Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2001 Type: Article